1. Home
  2. FXNC vs LCTX Comparison

FXNC vs LCTX Comparison

Compare FXNC & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First National Corporation

FXNC

First National Corporation

HOLD

Current Price

$29.86

Market Cap

268.4M

Sector

Finance

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$0.98

Market Cap

251.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FXNC
LCTX
Founded
1907
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
268.4M
251.4M
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
FXNC
LCTX
Price
$29.86
$0.98
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
★ $32.50
$5.50
AVG Volume (30 Days)
15.1K
★ 1.5M
Earning Date
11-06-2026
11-05-2026
Dividend Yield
★ 2.29%
N/A
EPS Growth
★ 96.00
N/A
EPS
★ 1.17
N/A
Revenue
$7,717,000.00
★ $14,556,000.00
Revenue This Year
$5.70
$4.38
Revenue Next Year
$4.38
$10.80
P/E Ratio
$25.49
★ N/A
Revenue Growth
7.40
★ 53.24
52 Week Low
$22.09
$0.88
52 Week High
$33.24
$2.09

Technical Indicators

Market Signals
Indicator
FXNC
LCTX
Relative Strength Index (RSI) 48.39 50.78
Support Level $28.72 $0.89
Resistance Level $30.41 $1.18
Average True Range (ATR) 0.63 0.06
MACD 0.05 0.01
Stochastic Oscillator 58.39 63.05

Price Performance

Historical Comparison
FXNC
LCTX

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: